When administering sodium thiosulfate for extravasation, what is the correct route?

Sodium thiosulfate is administered subcutaneously for the treatment of extravasation, which occurs when a chemotherapy agent leaks into the surrounding tissue. Using the subcutaneous route allows for targeted delivery to the affected area where the extravasation has occurred. This route is effective in neutralizing the harmful effects of certain chemotherapy agents that cause tissue damage when they extravasate, helping to reduce the risk of serious complications.

While other routes are considered for various medications, in the case of sodium thiosulfate, subcutaneous administration is specifically chosen to optimize its therapeutic effect at the site of tissue injury. This is crucial in managing extravasation to prevent further damage and promote better healing outcomes.